01
Cash & equivalents increased 9.9%
Cash & equivalents changed +9.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.1M→$6.7MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTLantern Pharma Inc.'s latest supported as-filed period reports net income of -$7.1M, 63.3% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +9.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -63.3% from the comparable as-filed period.
Operating income changed +24.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
LTRN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-037979SEC ↗10-QAug 14, 2026Period Jun 30, 20260001493152-26-037971SEC ↗8-KAug 3, 2026Period Aug 3, 20260001493152-26-035864SEC ↗8-KJun 2, 2026Period Jun 1, 20260001493152-26-026696SEC ↗8-KMay 15, 2026Period May 15, 20260001493152-26-023758SEC ↗10-QMay 15, 2026Period Mar 31, 20260001493152-26-023740SEC ↗8-KMay 14, 2026Period May 12, 20260001493152-26-023200SEC ↗4Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Research & development changed -41.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-023083